Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

GIVINOSTAT 8.86MG/ML ORAL SUSPENSION SUGAR-FREE, 140 mL

Belfast Health and Social Care Trust

This public procurement record has 2 releases in its history.

Award

08 Sep 2026 at 10:18

UK6 - Contract Award Notice
Award

07 Sep 2026 at 13:14

UK5 - Transparency Notice
Summary of the contracting process

Belfast Health & Social Care Trust procured GIVINOSTAT 8.86 mg/ml oral suspension, sugar-free, supplied in 140 ml packs of one. This is a pharmaceutical goods requirement for an essential patient-care medicine. The procurement covered one requirement and delivery within the United Kingdom. The Trust is the public healthcare buying organisation. The selected supplier, POLAR SPEED DISTRIBUTION LIMITED, is based in Bedfordshire and specialises in distribution. The requirement is specific to the named branded medicine and its stated formulation, rather than a general medicines supply arrangement. Businesses relevant to this market include pharmaceutical manufacturers, licensed distributors and specialist suppliers able to source and deliver patent-protected medicines for hospital use.

The procurement is complete and has reached the award stage: POLAR SPEED DISTRIBUTION LIMITED was selected through a direct award for the single requirement. The award was dated 8 September 2026 and has a value of £475,000 including tax. The award period runs from 19 September 2026 to 30 September 2027. The direct award was justified on the basis that GIVINOSTAT is a branded, patent-protected medicine essential to patient care and available from only one economic operator; the buyer stated that competition was not artificially narrowed. The award was above the relevant threshold. A standstill period runs until 18 September 2026, with signature scheduled for 19 September 2026. The award is recorded as pending signature.

This procurement indicates demand from Belfast Health & Social Care Trust for a highly specific, patient-critical pharmaceutical product rather than interchangeable general stock. A credible future competitor would need reliable access to GIVINOSTAT in the exact 8.86 mg/ml sugar-free oral suspension and 140 ml pack format, together with the legal right or manufacturer-authorised route to supply a branded patent-protected medicine. It would also need specialist pharmaceutical distribution capability, dependable hospital delivery across the United Kingdom, stock and continuity arrangements, and the capacity to support essential patient care without interruption. Suppliers should be able to demonstrate appropriate product provenance, regulatory compliance, handling controls and experience serving healthcare buyers with time-sensitive medicines.

How relevant is this notice?

Notice Information

Notice Title

GIVINOSTAT 8.86MG/ML ORAL SUSPENSION SUGAR-FREE, 140 mL

Notice Description

Procurement of GIVINOSTAT 8.86MG/ML ORAL SUSPENSION SUGAR-FREE, 140 mL

Procurement Information

These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06f376
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/084734-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK6 - Contract Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£475,000 £100K-£500K
Contracts Value
Not specified

Notice Dates

Publication Date
8 Sep 20261 weeks ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
8 Sep 20261 weeks ago
Contract Period
19 Sep 2026 - 30 Sep 2027 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Belfast Health and Social Care Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BELFAST
Postcode
BT12 6BA
Postcode Area
Northern Ireland
Country
Northern Ireland
Major Region (ITL 1)
TLN Northern Ireland
Basic Region (ITL 2)
TLN0 Northern Ireland
Small Region (ITL 3)
TLN06 Belfast
Delivery Location
Not specified
Local Authority
Belfast
Electoral Ward
Falls
Westminster Constituency
Belfast West

Supplier Information

Number of Suppliers
1
Supplier Name

Polar Speed Distribution Limited

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...